On (b)(6) 2020, neotract was made aware of a patient who underwent a successful prostatic urethral lift (pul) on (b)(6) 2020.He reportedly continued to experience undisclosed irritative symptoms.At an unspecified time later, the physician performed a turp of the median lobe to relieve the patient¿s symptoms.The symptoms persisted and the patient then disclosed a severe allergy to nickel, which was previously unknown to the physician.The physician prescribed benadryl and a medrol dose pack and inquired with neotract about removing the implants.The current status of the patient is unknown, and it is unknown if the physician will attempt to remove the implants.
|